Examining Volunteer Bias in Psychedelic Research.
Samantha G. Gomez, Fiona Low, Mitch Earleywine
Journal of Psychoactive Drugs October 8, 2025 DOI: 10.1080/02791072.2025.2570936 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Cross-sectional survey Peer reviewed |
|---|---|
| Sample size | 702 |
| Population | MTurk participants |
| Keywords | Psychedelic research Diversity Generalizability Inclusion Research participation Volunteer bias |
| Key findings | Psychedelic use increased willingness to participate in unpaid psychedelic studies, while demographic variables did not consistently predict volunteering. |
Abstract
Since its resurgence, psychedelic research has garnered considerable attention, especially in mental health. Preliminary findings have indicated positive results regarding psychedelic-assisted psychotherapy. Despite promising findings, various researchers have voiced concerns regarding psychedelic research and its potential for volunteer bias. Participants willing to participate in clinical trials, for example, might differ dramatically from the general population. The current study attempts to identify the potential volunteer bias that might contribute to current results. Participants recruited on MTurk (N = 702) provided demographic information as well as self-reported psychedelic use. We used binary logistic regressions to assess whether demographic and reported psychedelic use variables predicted willingness to participate in six hypothetical psychedelic studies. Results indicated that psychedelic use increased willingness to participate in a single unpaid survey, multiple unpaid surveys presented longitudinally, as well as an unpaid administration study. No demographic variables predicted volunteering consistently. Differences between paid and unpaid participation suggested that compensation might help reach broader samples. Given the implications related to volunteer bias and impeded generalizability, these findings indicate a need for further research to fully address the concern of volunteer bias in psychedelic research. Reaching those with less psychedelic experience will likely be imperative to investigations of clinical implications.
Citations in the library
Cited by 2
- Changes in neuroticism and values after naturalistic use of psychedelics and MDMA: a prospective survey study Journal of Affective Disorders Reports July 1, 2026
- The Ethnopharmacological Use of Mescaline for Psychiatric Disorders: A Systematic Review International Journal of Molecular Sciences March 28, 2026
Cites 20
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future. Neuropsychopharmacology April 26, 2017
- Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature BMC Psychiatry July 31, 2018
- A Single Ketamine Infusion Combined With Motivational Enhancement Therapy for Alcohol Use Disorder: A Randomized Midazolam-Controlled Pilot Trial. American Journal of Psychiatry December 2, 2019
- Single Versus Repeated Sessions of Ketamine-Assisted Psychotherapy for People with Heroin Dependence Journal of Psychoactive Drugs March 1, 2007
and 15 more in the library